{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:51:19Z","timestamp":1792734679787,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057658"],"award-info":[{"award-number":["R01DA057658"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Behav Health Serv Res"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Integrated treatment services for co-occurring mental health and substance use disorders are recommended best practice, yet their relationship with facility-level provision of detoxification and medications for opioid use disorder (MOUDs) is not well understood. The researchers analyzed 2021\u20132023 National Substance Use and Mental Health Services Survey (N-SUMHSS) data from 49,623 facilities offering any substance use services. Multivariable logistic regression models examined associations between integrated services and availability of detoxification and MOUD, adjusting for facility characteristics and Chronic Care Model elements. Primary treatment focus (substance use, mental health, mixed) was evaluated as an effect modifier. Overall, 61.2% of facilities offered integrated services, 21.2% provided detoxification, and 56.0% provided MOUD. Among substance use\u2013focused facilities, integrated services were associated with higher odds of offering detox (adjusted odds ratio [aOR]\u2009=\u20091.27, 95% CI 1.17\u20131.37) and MOUD (aOR\u2009=\u20091.44, 95% CI 1.34\u20131.56). Among mixed-focus facilities, integrated services were associated with higher odds of MOUD (aOR\u2009=\u20091.39, 95% CI 1.28\u20131.51) but not detoxification. Among mental health\u2013focused facilities, integrated services were associated with lower odds of detoxification (aOR\u2009=\u20090.34, 95% CI 0.22\u20130.53) and did not predict MOUD availability. Facility type, ownership, and Chronic Care Model elements, including delivery system redesign, self-management support, and clinical information systems, were strong independent predictors of both outcomes. Integrated services may be associated with greater access to detoxification and MOUD in substance use\u2013focused settings but appear insufficient within mental health\u2013focused facilities; efforts to strengthen integrated care should account for facility focus and infrastructure capacity.<\/jats:p>","DOI":"10.1007\/s11414-026-10003-9","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:18:15Z","timestamp":1780928295000},"page":"574-589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Integrated Treatment Services and Access to Detoxification and MOUD Across US Treatment Facilities"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-220X","authenticated-orcid":false,"given":"Fares","family":"Qeadan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falak","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Thornquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"10003_CR1","unstructured":"Mental Illness. Bethesda, Maryland: National Institute of Mental Health, 2024. Available at https:\/\/www.nimh.nih.gov\/health\/statistics\/mental-illness. Accessed 29 Jun 2025."},{"key":"10003_CR2","unstructured":"NIDA IC Fact Sheet 2024. North Bethesda, Maryland: National Institute on Drug Abuse, 2023. Available at https:\/\/nida.nih.gov\/about-nida\/legislative-activities\/budget-information\/fiscal-year-2024-budget-information-congressional-justification-national-institute-drug-abuse\/ic-fact-sheet-2024. Accessed 29 Jun 2025."},{"key":"10003_CR3","unstructured":"Co-Occurring Disorders and Other Health Conditions. Rockville, Maryland: Substance Abuse and Mental Health Services Administration, 2025. Available at https:\/\/www.samhsa.gov\/substance-use\/treatment\/co-occurring-disorders. Accessed 29 Jun 2025."},{"key":"10003_CR4","unstructured":"2022 National Survey on Drug Use and Health (NSDUH) Releases. Rockville, Maryland: National Survey on Drug Use and Health, 2022. Available at https:\/\/www.samhsa.gov\/data\/data-we-collect\/nsduh-national-survey-drug-use-and-health\/national-releases\/2022. Accessed 18 Jul 2025."},{"key":"10003_CR5","doi-asserted-by":"publisher","unstructured":"Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence 2019;197:78\u201382. Available at https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.12.030. Accessed 18 Jul 2025.","DOI":"10.1016\/j.drugalcdep.2018.12.030"},{"key":"10003_CR6","doi-asserted-by":"publisher","unstructured":"Herman SE, Frank KA, Mowbray CT, et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services & Research 2000;27(3):286\u2013302. Available at https:\/\/doi.org\/10.1007\/BF02291740. Accessed 8 Jul 2025.","DOI":"10.1007\/BF02291740"},{"key":"10003_CR7","doi-asserted-by":"publisher","unstructured":"Kelly TM, Daley DC. Integrated treatment of substance use and psychiatric disorders. Social Work in Public Health 2013;28(3\u20134):388\u2013406. Available at https:\/\/doi.org\/10.1080\/19371918.2013.774673 . Accessed 8 Jul 2025.","DOI":"10.1080\/19371918.2013.774673"},{"key":"10003_CR8","doi-asserted-by":"publisher","unstructured":"W\u00fcsthoff LE, Waal H, Gr\u00e5we RW. The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and\/or depression - a group randomized trial. BMC Psychiatry 2014;14(1):67. Available at https:\/\/doi.org\/10.1186\/1471-244X-14-67. Accessed 8 Jul 2025.","DOI":"10.1186\/1471-244X-14-67"},{"key":"10003_CR9","doi-asserted-by":"publisher","unstructured":"Drake RE, Mercer-McFadden C, Mueser KT, et al. Review of Integrated Mental Health and Substance Abuse Treatment for Patients With Dual Disorders. Schizophrenia Bulletin 1998;24(4):589\u2013608. Available at https:\/\/doi.org\/10.1093\/oxfordjournals.schbul.a033351. Accessed 8 Jul 2025.","DOI":"10.1093\/oxfordjournals.schbul.a033351"},{"key":"10003_CR10","doi-asserted-by":"publisher","unstructured":"Pettit Bruns D, Kraguljac NV. Co-occurring opioid use disorder and serious mental illness: A selective literature review. Journal of Nursing Scholarship 2023;55(3):646\u2013654. Available at https:\/\/doi.org\/10.1111\/jnu.12879. Accessed 8 Jul 2025.","DOI":"10.1111\/jnu.12879"},{"key":"10003_CR11","doi-asserted-by":"publisher","unstructured":"Grella CE, Stein JA. Impact of Program Services on Treatment Outcomes of Patients With Comorbid Mental and Substance Use Disorders. Psychiatric Services 2006;57(7):1007\u20131015. Available at https:\/\/doi.org\/10.1176\/ps.2006.57.7.1007. Accessed 8 Jul 2025.","DOI":"10.1176\/ps.2006.57.7.1007"},{"key":"10003_CR12","doi-asserted-by":"publisher","unstructured":"Ford JH, Kaur A, Rao D, et al. Improving medication access within integrated treatment for individuals with co-occurring disorders in substance use treatment agencies. Implementation Research and Practice 2021;2:26334895211033659. Available at https:\/\/doi.org\/10.1177\/26334895211033659. Accessed 8 Jul 2025.","DOI":"10.1177\/26334895211033659"},{"key":"10003_CR13","doi-asserted-by":"publisher","unstructured":"Harris KM, Edlund MJ. Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatric Services 2005;56(8):954\u20139. Available at https:\/\/doi.org\/10.1176\/appi.ps.56.8.954. Accessed 8 Jul 2025.","DOI":"10.1176\/appi.ps.56.8.954"},{"key":"10003_CR14","doi-asserted-by":"publisher","unstructured":"Adeniran E, Quinn M, Wallace R, et al. A scoping review of barriers and facilitators to the integration of substance use treatment services into US mainstream health care. Drug and Alcohol Dependence Reports 2023;7:100152. Available at https:\/\/doi.org\/10.1016\/j.dadr.2023.100152. Accessed 18 Jul 2025.","DOI":"10.1016\/j.dadr.2023.100152"},{"key":"10003_CR15","doi-asserted-by":"publisher","unstructured":"Carswell N, Angermaier G, Castaneda C et al. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting. Hospital Practice (1995) 2022;50(4):251\u2013258. Available at https:\/\/doi.org\/10.1080\/21548331.2022.2102776. Accessed 8 Jul 2025.","DOI":"10.1080\/21548331.2022.2102776"},{"key":"10003_CR16","doi-asserted-by":"publisher","unstructured":"Nunes EV, Gordon M, Friedmann PD, et al. Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone. Journal of Substance Abuse Treatment 2018;85:49\u201355. Available at https:\/\/doi.org\/10.1016\/j.jsat.2017.04.016. Accessed 8 Jul 2025.","DOI":"10.1016\/j.jsat.2017.04.016"},{"key":"10003_CR17","doi-asserted-by":"publisher","unstructured":"MacKinnon L, Choi J, Kennedy MC, et al. Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment. Journal of Addiction Medicine 2022;16(6):653\u2013658. Available at https:\/\/doi.org\/10.1097\/ADM.0000000000000984. Accessed 8 Jul 2025.","DOI":"10.1097\/ADM.0000000000000984"},{"key":"10003_CR18","doi-asserted-by":"publisher","unstructured":"Timko C, Schultz NR, Cucciare MA et al. Retention in medication-assisted treatment for opiate dependence: A systematic review. Journal of Addictive Diseases 2016;35(1):22\u201335. Available at https:\/\/doi.org\/10.1080\/10550887.2016.1100960. Accessed 18 Jul 2025.","DOI":"10.1080\/10550887.2016.1100960"},{"key":"10003_CR19","doi-asserted-by":"publisher","unstructured":"Oesterle TS, Thusius NJ, Rummans TA et al. Medication-Assisted Treatment for Opioid-Use Disorder. Mayo Clinic Proceedings 2019;94(10):2072\u20132086. Available at https:\/\/doi.org\/10.1016\/j.mayocp.2019.03.029. Accessed 8 Jul 2025.","DOI":"10.1016\/j.mayocp.2019.03.029"},{"key":"10003_CR20","doi-asserted-by":"publisher","unstructured":"Wakeman SE, Larochelle MR, Ameli O, et al. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. Journal of the American Medical Association Network Open 2020;3(2):e1920622-e1920622. Available at https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20622. Accessed 8 Jul 2025.","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"10003_CR21","doi-asserted-by":"publisher","unstructured":"David AR, Sian CR, Gebel CM, et al. Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study. Journal of Substance Abuse Treatment 2022;142:108870. Available at https:\/\/doi.org\/10.1016\/j.jsat.2022.108870. Accessed 18 Jul 2025.","DOI":"10.1016\/j.jsat.2022.108870"},{"key":"10003_CR22","doi-asserted-by":"publisher","unstructured":"Bremer W, Plaisance K, Walker D, et al. Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature. Front Public Health 2023;11:1141093. Available at https:\/\/doi.org\/10.3389\/fpubh.2023.1141093. Accessed 18 Jul 2025.","DOI":"10.3389\/fpubh.2023.1141093"},{"key":"10003_CR23","doi-asserted-by":"publisher","unstructured":"Madras BK, Ahmad NJ, Wen J et al. Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System. NAM Perspectives 2020. Available at https:\/\/doi.org\/10.31478\/202004b. Accessed 18 Jul 2025.","DOI":"10.31478\/202004b"},{"key":"10003_CR24","doi-asserted-by":"publisher","unstructured":"Hser YI, Zhu Y, Baldwin LM et al. Medication treatment for opioid use disorder among rural primary care patients. Journal of Rural Health 2024;40(1):195\u2013199. Available at https:\/\/doi.org\/10.1111\/jrh.12785. Accessed 8 Jul 2025.","DOI":"10.1111\/jrh.12785"},{"key":"10003_CR25","doi-asserted-by":"publisher","unstructured":"Spivak S, Strain EC, Spivak A, et al. Integrated dual diagnosis treatment among United States mental health treatment facilities: 2010 to 2018. Drug and Alcohol Dependence 2020;213:108074. Available at https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108074. Accessed 8 Jul 2025.","DOI":"10.1016\/j.drugalcdep.2020.108074"},{"key":"10003_CR26","doi-asserted-by":"publisher","unstructured":"Donabedian A. The quality of care. How can it be assessed?. Journal of the American Medical Association 1988; 260(12), 1743\u20131748. Available at https:\/\/doi.org\/10.1001\/jama.260.12.1743. Accessed 25 Mar 2026.","DOI":"10.1001\/jama.260.12.1743"},{"key":"10003_CR27","unstructured":"About N-SUMHSS. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2025. Available at https:\/\/www.samhsa.gov\/data\/data-we-collect\/n-sumhss-national-substance-use-and-mental-health-services-survey\/about. Accessed 19 Jun 2025."},{"key":"10003_CR28","unstructured":"Substance Abuse and Mental Health Services Administration. National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: Data on Substance Use and Mental Health Treatment Facilities. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2022. Publication No. PEP23\u201307\u201300\u2013001. Available at https:\/\/library.samhsa.gov\/sites\/default\/files\/pep23-07-00-001.pdf. Accessed 19 Jun 2025."},{"key":"10003_CR29","unstructured":"Substance Abuse and Mental Health Services Administration. National Substance Use and Mental Health Services Survey (N-SUMHSS) 2022: Data on Substance Use and Mental Health Treatment Facilities. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2023. Publication No. PEP23-07-00-002 Available at https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt42711\/2022-nsumhss-annual-report.pdf. Accessed 19 Jun 2025."},{"key":"10003_CR30","unstructured":"Substance Abuse and Mental Health Services Administration. National Substance Use and Mental Health Services Survey (N-SUMHSS), 2023: Data on Substance Use and Mental Health Treatment Facilities. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2024. Publication No. PEP24-07- 027 Available at https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt53012\/2023-nsumhss-annual-report.pdf. Accessed 19 Jun 2025."},{"key":"10003_CR31","doi-asserted-by":"publisher","unstructured":"Watkins KE, Hunter SB, Wenzel SL, et al. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. American Journal of Drug and Alcohol Abuse 2004;30(4):749\u201364. Available at https:\/\/doi.org\/10.1081\/ada-200037538. Accessed 8 Jul 2025.","DOI":"10.1081\/ada-200037538"},{"key":"10003_CR32","doi-asserted-by":"publisher","unstructured":"Gee PM, Greenwood DA, Paterniti DA et al. The eHealth Enhanced Chronic Care Model: a theory derivation approach. Journal of Medical Internet Research 2015;17(4):e86. Available at https:\/\/doi.org\/10.2196\/jmir.4067. Accessed 30 Nov 2025.","DOI":"10.2196\/jmir.4067"},{"key":"10003_CR33","unstructured":"Substance Abuse and Mental Health Services Administration (US); 1997. Treatment Improvement Protocol (TIP) Series, No. 24. A Guide to Substance Abuse Services for Primary Care Clinicians. Rockville, MD: Center for Substance Abuse Treatment. Available at https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64827\/. Accessed 10 Nov 2025."},{"key":"10003_CR34","doi-asserted-by":"publisher","unstructured":"Garrison YL, Luo Y, Sahker E. Integration of substance use disorder treatment in traditional mental health facilities: Timeseries and cross-sectional evaluations. International Journal of Drug Policy 2024;124:104312. Available at https:\/\/doi.org\/10.1016\/j.drugpo.2023.104312. Accessed 30 Oct 2025.","DOI":"10.1016\/j.drugpo.2023.104312"},{"key":"10003_CR35","doi-asserted-by":"publisher","unstructured":"Jacobson N, Horst J, Wilcox-Warren L, et al. Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use. Journal of Behavioral Health Services & Research 2020;47(4):439\u2013448. Available at https:\/\/doi.org\/10.1007\/s11414-020-09706-4. Accessed 30 Oct 2025.","DOI":"10.1007\/s11414-020-09706-4"},{"key":"10003_CR36","doi-asserted-by":"publisher","unstructured":"Mackey K, Veazie S, Anderson J et al. Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review. Journal of General Internal Medicine 2020;35(Suppl 3):954\u2013963. Available at https:\/\/doi.org\/10.1007\/s11606-020-06257-4. Accessed 30 Oct 2025.","DOI":"10.1007\/s11606-020-06257-4"},{"key":"10003_CR37","doi-asserted-by":"publisher","unstructured":"Cantor J, Griffin BA, Levitan B, et al. Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities. Journal of the American Medical Association Network Open 2024;7(6):e2417545. Available at https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.17545. Accessed 30 Oct 2025.","DOI":"10.1001\/jamanetworkopen.2024.17545"},{"key":"10003_CR38","doi-asserted-by":"publisher","unstructured":"Wagner EH, Austin BT, Davis C et al. Improving chronic illness care: translating evidence into action. Health Affairs (Millwood) 2001;20(6):64\u201378. Available at https:\/\/doi.org\/10.1377\/hlthaff.20.6.64. Accessed 30 Oct 2025.","DOI":"10.1377\/hlthaff.20.6.64"},{"key":"10003_CR39","doi-asserted-by":"publisher","unstructured":"Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002;288(15):1909\u201314. Available at https:\/\/doi.org\/10.1001\/jama.288.15.1909. Accessed 30 Oct 2025.","DOI":"10.1001\/jama.288.15.1909"},{"key":"10003_CR40","doi-asserted-by":"publisher","unstructured":"Bachhuber MA, Southern WN, Cunningham CO. Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States. Medical Care 2014;52(5):428\u201334. Available at https:\/\/doi.org\/10.1097\/MLR.0000000000000121. Accessed 30 Oct 2025.","DOI":"10.1097\/MLR.0000000000000121"},{"key":"10003_CR41","doi-asserted-by":"publisher","unstructured":"Lindenfeld Z, Cantor JH, Mauri AI et al. Availability of Medications for Opioid Use Disorder in Opioid Treatment Programs. Journal of the American Medical Association Network Open 2025;8(6):e2517616. Available at https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.17616. Accessed 30 Oct 2025.","DOI":"10.1001\/jamanetworkopen.2025.17616"},{"key":"10003_CR42","doi-asserted-by":"publisher","unstructured":"Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Evaluation and Program Planning 2011;34(4):375\u201381. Available at https:\/\/doi.org\/10.1016\/j.evalprogplan.2011.02.004. Accessed 30 Oct 2025.","DOI":"10.1016\/j.evalprogplan.2011.02.004"},{"key":"10003_CR43","doi-asserted-by":"publisher","unstructured":"Knudsen HK, Roman PM. Financial factors and the implementation of medications for treating opioid use disorders. Journal of Addiction Medicine 2012;6(4):280\u20136. Available at https:\/\/doi.org\/10.1097\/ADM.0b013e318262a97a. Accessed 10 Nov 2025.","DOI":"10.1097\/ADM.0b013e318262a97a"},{"key":"10003_CR44","doi-asserted-by":"publisher","unstructured":"Snell-Rood C, Pollini RA, Willging C. Barriers to Integrated Medication-Assisted Treatment for Rural Patients With Co-occurring Disorders: The Gap in Managing Addiction. Psychiatric Services 2021;72(8):935\u2013942. Available at https:\/\/doi.org\/10.1176\/appi.ps.202000312. Accessed 8 Jul 2025.","DOI":"10.1176\/appi.ps.202000312"},{"key":"10003_CR45","doi-asserted-by":"publisher","unstructured":"Lin LA, Casteel D, Shigekawa E et al. Telemedicine-delivered treatment interventions for substance use disorders: A systematic review. Journal of Substance Abuse Treatment 2019;101:38\u201349. Available at https:\/\/doi.org\/10.1016\/j.jsat.2019.03.007. Accessed 30 Oct 2025.","DOI":"10.1016\/j.jsat.2019.03.007"},{"key":"10003_CR46","doi-asserted-by":"publisher","unstructured":"Qeadan F, Shimizu S, Tingey B et al. The impact of increased telehealth use on the treatment of substance use disorder during the COVID-19 pandemic. SSM - Population Health 2025;30:101780. Available at https:\/\/doi.org\/10.1016\/j.ssmph.2025.101780. Accessed 30 Oct 2025.","DOI":"10.1016\/j.ssmph.2025.101780"},{"key":"10003_CR47","doi-asserted-by":"publisher","unstructured":"Harris LM, Guerrero EG, Khachikian T et al. Expert providers implement integrated and coordinated care in opioid use disorder treatment. International Journal of Drug Policy 2024;132:104567. Available at https:\/\/doi.org\/10.1016\/j.drugpo.2024.104567. Accessed 10 Nov 2025.","DOI":"10.1016\/j.drugpo.2024.104567"},{"key":"10003_CR48","doi-asserted-by":"publisher","unstructured":"Vasko JM, Orey ES, Wartman C, et al. Leveraging pharmacy partnerships and Grant funding to improve access to medications for opioid use disorder. Exploratory Research in Clinical and Social Pharmacy 2025;20:100653. Available at https:\/\/doi.org\/10.1016\/j.rcsop.2025.100653. Accessed 10 Nov 2025.","DOI":"10.1016\/j.rcsop.2025.100653"}],"container-title":["The Journal of Behavioral Health Services &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-026-10003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11414-026-10003-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-026-10003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:38:43Z","timestamp":1791826723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11414-026-10003-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10003"],"URL":"https:\/\/doi.org\/10.1007\/s11414-026-10003-9","relation":{},"ISSN":["1094-3412","1556-3308"],"issn-type":[{"value":"1094-3412","type":"print"},{"value":"1556-3308","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed by the Loyola University Chicago Institutional Review Board (LU# 219811) and determined to be exempt under 45 CFR 46.104(d)(4)(i) as secondary research using publicly available, de-identified data. In accordance with this determination, the requirement for informed consent was waived.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"STROBE (Strengthening the Reporting of Observational Studies in Epidemiology).","order":3,"name":"Ethics","label":"Reporting Guideline","group":{"name":"EthicsHeading","label":"Declarations"}}]}}